Neuroone Medical Technologies (NMTC) Depreciation & Amortization (CF) (2019 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Depreciation & Amortization (CF) came in at $60029.0 in Q1 2026, down 8.54% YoY from $65634.0 in Q1 2025, and down 8.38% on a QoQ basis from $65523.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $60029.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 8.54% year-over-year to $60029.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $256470.0 (down 0.59% YoY) and the FY2025 annual result came in at $261679.0, up 6.03% from the prior year.
- Depreciation & Amortization (CF) eased to $60029.0 in Q1 2026, from $65523.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $66594.0 in Q2 2025 to a low of $28531.0 in Q1 2022.
- A 5-year average of $54514.5 and a median of $60900.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 87.03% — and 2026, when it slipped 8.54%.
- Tracing NMTC's Depreciation & Amortization (CF) over 5 years: stood at $35889.0 in 2022, then jumped by 63.44% to $58657.0 in 2023, then advanced by 11.03% to $65127.0 in 2024, then increased by 0.61% to $65523.0 in 2025, then retreated by 8.38% to $60029.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $60029.0 (Q1 2026), $65523.0 (Q4 2025), and $64324.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Neuroone Medical Technologies | 19.89 Mn | 17.84 Mn | 1.18 Mn | 47,002.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47,002.00 |
| Jun 30, 2026 | 47,002.00 |
| Mar 31, 2026 | 60,029.00 |
| Mar 31, 2026 | 60,029.00 |
| Dec 31, 2025 | 65,523.00 |
| Dec 31, 2025 | 65,523.00 |
| Sep 30, 2025 | 64,324.00 |
| Sep 30, 2025 | 64,324.00 |
| Jun 30, 2025 | 66,594.00 |
| Jun 30, 2025 | 66,594.00 |
| Mar 31, 2025 | 65,634.00 |
| Mar 31, 2025 | 65,634.00 |
| Dec 31, 2024 | 65,127.00 |
| Dec 31, 2024 | 65,127.00 |
| Sep 30, 2024 | 64,127.00 |
| Sep 30, 2024 | 64,127.00 |
| Jun 30, 2024 | 63,107.00 |
| Jun 30, 2024 | 63,107.00 |
| Mar 31, 2024 | 60,900.00 |
| Mar 31, 2024 | 60,900.00 |